Indivior Future Growth

Future criteria checks 4/6

Indivior is forecast to grow earnings and revenue by 49.4% and 5.5% per annum respectively. EPS is expected to grow by 46.7% per annum. Return on equity is forecast to be 203.4% in 3 years.

Key information

49.4%

Earnings growth rate

46.7%

EPS growth rate

Pharmaceuticals earnings growth21.2%
Revenue growth rate5.5%
Future return on equity203.4%
Analyst coverage

Good

Last updated25 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:2IVB - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,2103172723115
12/31/20251,1011891452097
12/31/20241,15775120167
9/30/20241,182-3-273-240N/A
6/30/20241,147-141-279-227N/A
3/31/20241,1245-383-334N/A
12/31/20231,0932-368-315N/A
9/30/20231,042-235-89-52N/A
6/30/20231,002-59-22-11N/A
3/31/2023947-502335N/A
12/31/2022901-53-9-4N/A
9/30/2022882166176181N/A
6/30/2022838152160145N/A
3/31/2022818166175189N/A
12/31/2021791205339353N/A
9/30/2021753156101115N/A
6/30/202172513981115N/A
3/31/2021674953942N/A
12/31/2020647-148-197-193N/A
9/30/2020595-190-84-82N/A
6/30/2020634-152-70-69N/A
3/31/2020700-95-131-130N/A
12/31/2019785134148151N/A
9/30/2019889213217200N/A
6/30/2019935254281275N/A
3/31/2019988248401413N/A
12/31/20181,005275299303N/A
9/30/20181,033106247276N/A
6/30/20181,06467N/A210N/A
3/31/20181,08371N/A260N/A
12/31/20171,09358N/A295N/A
9/30/20171,087281N/A360N/A
6/30/20171,08081N/A409N/A
3/31/20171,06565N/A370N/A
12/31/20161,05835N/A407N/A
9/30/20161,047-6N/A326N/A
6/30/20161,028191N/A283N/A
3/31/20161,021201N/A252N/A
12/31/20151,014228N/A320N/A
9/30/20151,037268N/A300N/A
6/30/20151,058314N/A369N/A
3/31/20151,085361N/A530N/A
12/31/20141,115403N/A440N/A
9/30/20141,147443N/A572N/A
12/31/20131,216489N/A791N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2IVB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: 2IVB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 2IVB is expected to become profitable in the next 3 years.

Revenue vs Market: 2IVB's revenue (5.5% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: 2IVB's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 2IVB's Return on Equity is forecast to be very high in 3 years time (203.4%).


Discover growth companies